Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: According to one embodiment, a lamp apparatus includes a light-emitting module, housing, and a lighting circuit. The light-emitting module includes a light-emitting element. The housing opens in the direction of irradiation of a light beam and having a cap on a side opposite from the direction of irradiation of the light beam. The cap is provided with a light-emitting module mounting portion projecting in the direction of irradiation of the light beam and the light-emitting module is mounted on the light-emitting module mounting portion. The lighting circuit is accommodated in the housing.

Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: The present invention provides a p27 protein inducing agent comprising a compound represented by general formula (11) below or pharmaceutically acceptable salt thereof as an active ingredient: wherein G1, G2, G3 and G8 are each independently selected from —N? etc., Ring G6 is selected from divalent aryl etc., A is selected from amino etc., G4 is selected from oxygen etc., G5 is selected from oxygen etc., G7 is selected from —CH2— etc., and R2 is selected from C1-6 alkyl etc.

Abstract: According to one embodiment, a lamp apparatus includes a light-emitting module, housing, and a lighting circuit. The light-emitting module includes a light-emitting element. The housing opens in the direction of irradiation of a light beam and having a cap on a side opposite from the direction of irradiation of the light beam. The cap is provided with a light-emitting module mounting portion projecting in the direction of irradiation of the light beam and the light-emitting module is mounted on the light-emitting module mounting portion. The lighting circuit is accommodated in the housing.

Abstract: When an operator operates an operation tool of a dimming operation terminal device in order to set the brightness of a lighting load to desired brightness, an energization electric signal, for example, a voltage level detected by a dimming control section changes. The dimming control section generates a dimming signal modulated according to the voltage level. Power supply to the dimming control section is performed by an insulated auxiliary power supply. Transmission of the dimming signal is performed via an insulating section.

Abstract: The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y1 and Y2 are selected from —N? etc., Y3 and Y4 are selected from —CH? etc., A is selected from sulfamide etc., R1 is selected from hydrogen etc., and R2 is selected from C1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

Abstract: According to one embodiment, a light source is mounted on one side of a base body, a cap is mounted on the other side of the base body and a lighting circuit is mounted in the cap. In the cap, a circumferential portion is formed, and a projection portion being projected from the other side of the circumferential portion and having an inner space opened to the one side is formed. The lighting circuit has a substrate and a plurality of components mounted on the substrate. The components include a first component group mounted on a center portion of the substrate and having a height stored in the projection portion and a second component group mounted on a peripheral portion of the substrate and having a smaller height stored in the circumferential portion.

Abstract: The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y1 and Y2 are selected from —N? etc., Y3 and Y4 are selected from —CH? etc., A is selected from sulfamide etc., R1 is selected from hydrogen etc., and R2 is selected from C1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

Abstract: The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y1 and Y2 are selected from —N? etc., Y3 and Y4 are selected from —CH? etc., A is selected from sulfamide etc., R1 is selected from hydrogen etc., and R2 is selected from C1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

Abstract: The present invention provides a p27 protein inducing agent comprising a compound represented by general formula (11) below or pharmaceutically acceptable salt thereof as an active ingredient: wherein G1, G2, G3 and G8 are each independently selected from —N? etc., Ring G6 is selected from divalent aryl etc., A is selected from amino etc., G4 is selected from oxygen etc., G5 is selected from oxygen etc., G7 is selected from —CH2— etc., and R2 is selected from C1-6 alkyl etc.

Abstract: The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y1 and Y2 are selected from —N? etc., Y3 and Y4 are selected from —CH? etc., A is selected from sulfamide etc., R1 is selected from hydrogen etc., and R2 is selected from C1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

Abstract: A motion picture film having digital audio data recorded in at least one sound track thereof. Such digital audio data includes a plurality of bytes of data each having 8 bits of data. Each respective bit of each byte of audio data is recorded in a sound track of the film in the film running direction and each byte is arranged side-by-side in a direction normal to the film running direction to form a compression processing block. C1 parity data is added to each such compression processing block and C2 parity data is added after a predetermined interval of plural compression processing blocks. Error correction may be performed by utilizing the C1 and C2 parity data for each compression processing block and at the predetermined interval of plural compression blocks.

Abstract: A motion picture film capable of reproducing the sound field full of ambience in the reproducing system. The digital sound tracks 5L and 5R, on which digital audio data have been recorded, are recorded so that temporally same digital audio signals are recorded with a spatial shift by a preset distance along the film running direction.

Abstract: A motion picture film capable of reproducing the sound field full of ambience in the reproducing system. The digital sound tracks 5L and 5R, on which digital audio data have been recorded, are recorded so that temporally same digital audio signals are recorded with a spatial shift by a preset distance along the film running direction.

Abstract: A motion picture film capable of reproducing the sound field full of ambience in the reproducing system. The digital sound tracks 5L and 5R, on which digital audio data have been recorded, are recorded so that temporally same digital audio signals are recorded with a spatial shift by a preset distance along the film running direction.

Abstract: In a time base correcting apparatus in which incoming video signals are written into a memory by write clock signals modulated by time base errors and the written video signals are read from the memory by read clock signals modulated by the velocity errors; the write clock signals and the read clock signals have different frequencies and fluctuations in the sampling positions due to the frequency differential between the write clock signals and the read clock signals are corrected by the phase modulation of the read clock signals.